Rankings
▼
Calendar
RMD Q2 2025 Earnings — ResMed Inc. Revenue & Financial Results | Market Cap Arena
RMD
ResMed Inc.
$36B
Q2 2025 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$1.3B
+10.3% YoY
Gross Profit
$751M
58.6% margin
Operating Income
$417M
32.5% margin
Net Income
$345M
26.9% margin
EPS (Diluted)
$2.34
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
$309M
Free Cash Flow
$290M
Stock-Based Comp.
$23M
Balance Sheet
Total Assets
$7.1B
Total Liabilities
$1.9B
Stockholders' Equity
$5.3B
Cash & Equivalents
$522M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1.3B
$1.2B
+10.3%
Gross Profit
$751M
$669M
+12.2%
Operating Income
$417M
$275M
+51.7%
Net Income
$345M
$209M
+65.0%
Revenue Segments
Sleep And Respiratory
$1.1B
88%
Residential Care Software
$156M
12%
Geographic Segments
Us Canada And Latin America
$749M
58%
Combined Europe Asia And Other Markets
$377M
29%
Global
$156M
12%
← FY 2025
All Quarters
Q3 2025 →